CDK18 and cancer: Due to its cellular functions, CDK18 therefore represents a potential novel anti-cancer drug target, both as a mono-therapeutic approach in cancers with high levels of replication stress, and as part of combination approaches with chemotherapeutic agents that induce high levels of replication stress and/or DNA damage.